Weak regulation leaves global pharma industry vulnerable to corruption, campaigners say
MLex Summary: A weak legislative and regulatory framework across the globe is leaving the pharmaceutical sector exposed to several corruption risks, according to a report by Transparency International UK.The full statement follows and...To view the full article, register now.
Already a subscriber? Click here to view full article